Gender differences in achieving optimal lipid goals in patients with coronary artery disease

Area of Science:

• Cardiology
• Clinical Lipidology
• Health Disparities

Background:

• Coronary artery disease (CAD) management requires optimal lipid control.
• Gender-based differences in cardiovascular disease treatment and outcomes are increasingly recognized.
• Achieving lipid goals is crucial for secondary prevention in CAD patients.

Purpose of the Study:

• To investigate gender-specific differences in lipid goal attainment among patients with coronary artery disease.
• To identify potential factors contributing to these differences, focusing on lipid-lowering medication use.

Main Methods:

• Retrospective analysis of electronic health records from a large cardiology practice (September 2008-September 2009).
• Inclusion of 9,950 patients with coronary artery disease, with extraction of lipid profiles and medication data.
• Comparison of lipid goal attainment (LDL-C <70 mg/dL, non-HDL-C <100 mg/dL) and medication use between men and women.

Main Results:

• Women (34%) were less likely than men to achieve low-density lipoprotein (LDL) cholesterol goals (30.6% vs 38.4%, p <0.001) and non-high-density lipoprotein (non-HDL) cholesterol goals (37.1% vs 48.2%, p <0.001).
• Women received less potent statin therapy and combination therapy compared to men.
• Women were more likely to be on no statin or any lipid-lowering therapy.

Conclusions:

• Women with coronary artery disease exhibit significant underachievement of lipid goals compared to men.
• Prescribed lipid-lowering therapies, including statin doses and combination treatments, are insufficient in women.
• Addressing gender disparities in lipid management is essential for improving cardiovascular outcomes in women with CAD.